Concepedia

Stephen J. Rossi

SJ

41

Publications

4K

Citations

27

H-Index

1992

Active since

Affiliations

NGM Biopharmaceuticals (United States)(Current)

Georgia Southern University

Duke University

University of California San Diego

San Francisco VA Medical Center

Stephen J. Rossi is an author at NGM Biopharmaceuticals (United States) specializing in medicine, hepatology, and immunology.

Top concepts

Publications per year

1992–2019

41

Publications

41

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*

Kenneth S. Lown, Robert R. Mayo, Alan B. Leichtman et al. · Clinical Pharmacology & Therapeutics · 1997 · 683 citations · Full text

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Stephen A. Harrison, Mary E. Rinella, Manal F. Abdelmalek et al. · The Lancet · 2018 · 404 citations

, , +5

Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice

Phillipp Hartmann, K Hochrath, Angela Horvath et al. · Hepatology · 2017 · 268 citations · Full text

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis

Stephen A. Harrison, Stephen J. Rossi, Angelo H. Paredes et al. · Hepatology · 2019 · 251 citations · Full text

, , +24

Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis

Katharina Brandl, Phillipp Hartmann, Lily Jih et al. · Journal of Hepatology · 2018 · 201 citations · Full text

, , +11

Rows per page

1–5 of 41